-
Poly-PR, TDP-43 Condensation, and HSP70
2026-09-19
The reference study identifies a time-dependent mechanism linking C9ORF72-derived poly-PR stress to NEAT1-dependent TDP-43 nuclear condensation and altered HSP70 localization. Its findings position HSP70 as a regulator of condensate fluidity and TDP-43 proteostasis, while highlighting important limits when translating this neurodegenerative disease mechanism to other research settings.
-
Carboplatin Beyond DNA Damage: A Metabolic Lens
2026-09-19
Carboplatin is best known as a platinum-based DNA synthesis inhibitor, but its translational value extends beyond a conventional cytotoxicity readout. By integrating Carboplatin response studies with evidence that CIP2A drives PKM2 tetramerization and oxidative phosphorylation in non-small cell lung cancer, researchers can investigate how tumor metabolism, DNA damage, and model architecture jointly shape treatment response.
-
SB-3CT and MMP9: From PNNs to Translation
2026-09-18
A thought-leadership framework for using SB-3CT as a mechanistic gelatinase inhibitor in perineuronal-net, tumor metastasis, angiogenesis, and cerebral ischemia research—while preserving the distinction between pharmacological probing and clinical evidence.
-
Dhcr7 Editing Improves GCRV Resistance in Grass Carp
2026-09-18
A 2026 Aquaculture Reports study used CRISPR/Cas9 to disrupt dhcr7 in grass carp and identified DHCR7-dependent sterol metabolism as an in vivo determinant of resistance to lethal GCRV-II infection. Edited fish showed higher survival, stronger Irf3-associated antiviral responses, lower viral burden, and less hepatopancreas injury without detectable defects in measured growth or muscle morphology.
-
Reversine for Reliable Mitotic Assays
2026-09-17
This scenario-driven guide explains how Reversine (SKU A3760) can support interpretable proliferation, viability, and apoptosis experiments through defined Aurora kinase pharmacology and practical handling controls. It also separates product-backed evidence from workflow recommendations and cautions against transferring cancer-cell findings directly to gastruloid models.
-
Ionomycin Calcium Salt in Ca2+ Influx Assays
2026-09-17
Ionomycin calcium salt is a versatile calcium ionophore for imposing controlled intracellular Ca2+ perturbations in cancer and cell-signaling studies. This article explains how to use it alongside the TSPAN18–STIM1–Orai1 model to distinguish calcium sufficiency from pathway-specific regulation.
-
REV1–DHX36 Coordination at G-Quadruplex DNA
2026-09-16
The 2026 Nucleic Acids Research study identifies a direct REV1–DHX36 interaction that coordinates G-quadruplex unwinding, replication-fork progression, and suppression of single-stranded DNA gaps. Its two-tier model clarifies how cells tolerate stabilized G4 DNA while linking replication stress to ATM/ATR signaling and potential cancer research applications.
-
(S)-(+)-Dimethindene maleate: Lab Guide
2026-09-15
This guide explains how to use (S)-(+)-Dimethindene maleate, SKU B6734, when an experiment requires pharmacological perturbation of M2 muscarinic and H1 histamine receptors. It focuses on assay setup, solution handling, controls, and interpretation boundaries rather than therapeutic or diagnostic use.
-
hCG, H3K27 Methylation, and CXCL10 in Decidua
2026-09-15
Silasi and colleagues showed that human chorionic gonadotropin suppresses decidual CXCL10 by promoting EZH2-dependent H3K27me3 deposition at the CXCL10 promoter. This mechanism links placental endocrine signaling with local control of CD8-cell recruitment and provides a useful framework for studying epigenetic regulation at the maternal–fetal interface.
-
Linezolid vs MmpL3: A Smarter Assay Strategy
2026-09-14
Linezolid provides a mechanistically defined benchmark for inhibition of bacterial protein synthesis, while spirocyclic POM compound 5c illustrates target-led tuberculosis discovery. This article shows how to compare these systems without confusing assay potency, species biology, or translational maturity.
-
Methylprednisolone: Reliable Assay Workflows
2026-09-14
This scenario-based guide shows how Methylprednisolone SKU A4233 can support reproducible inflammatory, viability, proliferation, and glucocorticoid-injury workflows. It combines practical formulation guidance with evidence from macrophage, immune-cell, and methylprednisolone-induced osteonecrosis research.
-
LGK-974: Translating PORCN Inhibition into Wnt Strategy
2026-09-13
A translational framework for using LGK-974 as a PORCN inhibitor to interrogate Wnt dependency, pancreatic cancer RNF43 mutation biology, pathway biomarkers, and combination strategies in Wnt-driven cancer research.
-
Vidarabine monohydrate: Assay Design
2026-09-12
Vidarabine monohydrate is more than a conventional antiviral reference compound. This guide presents a mechanism-to-measurement framework for controlling solubility, separating antiviral activity from cytotoxicity, and using orthogonal assays to interpret viral DNA synthesis results.
-
DiscoveryProbe™ Metabolism-related Compound Library
2026-09-12
The DiscoveryProbe™ Metabolism-related Compound Library provides a standardized set of 493 metabolism-focused small molecules for enzyme, pathway, cell-based, and ex vivo screening. It is intended for research use only; compound-specific activity, selectivity, toxicity, and clinical relevance must be established experimentally rather than inferred from the library description.
-
Deferasirox in Ferroptosis Research
2026-09-11
Deferasirox is an oral iron chelator that helps researchers manipulate labile iron, ferroptosis resistance, and tumor-cell stress in controlled models. This guide translates the METTL16-SENP3-LTF findings in hepatocellular carcinoma into practical dosing, assay, workflow, and troubleshooting decisions.